Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis

Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis

The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at >10% per year, reaching up to 80–90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, the diagnostic screening of MCI is crucial for detecting individ...

Full description

Bibliographic Details
Main Authors: Natalia Ogonowski, Stefanny Salcidua, Tomas Leon, Nayaret Chamorro-Veloso, Cristian Valls, Constanza Avalos, Alejandro Bisquertt, Miguel E. Rentería, Paulina Orellana, Claudia Duran-Aniotz
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
systematic review
microRNA
biomarkers
fluid biomarkers
diagnosis
mild cognitive impairment
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.807764/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.807764/full

Similar Items